"Risk Factors for Drug-Resistant Tuberculosis"
written by Marta Gomes, Ana Correia, Denisa Mendonça, Raquel Duarte,
published by Journal of Tuberculosis Research, Vol.2 No.3, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] DETERMINATION OF MAJOR FACTORS PREDICTING MDRTB AMONG PRESUMPTIVE MDRTB CASES IN PLATEAU STATE–NIGERIA
2020
[2] Analysis of drug susceptibility patterns in tuberculosis diagnosed cases from Ecuador during 2012-2017
2020
[3] Increasing Burden of Multidrug Resistant Tuberculosis in HIV Infected Individuals: A Systematic Review and Meta-Analysis
2020
[4] RISK FACTORS FOR MULTI DRUG-RESISTANT TUBERCULOSIS AMONG TUBERCULOSIS PATIENTS OF NEKEMTE REFERRAL HOSPITAL, OROMIA REGIONAL STATE, WESTERN ETHIOPIA
Scientific Research and Reviews, 2019
[5] Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia
Thesis, 2019
[6] Karakteristike toka plućne tuberkuloze kod obolelih od šećerne bolesti
2019
[7] Penanganan Tuberkulosis Resistan Obat pada Daerah Terpencil: Mission Impossible?
2019
[8] RISK FACTORS FOR MULTI DR TUBERCULOSIS PATIENTS OF N REGIONAL STATE
2019
[9] Association between DOTS program and the outcome of previous therapy in MDR-TB patients: a case study in Tasikmalaya district, West Java, Indonesia
2019
[10] Determinants of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients in Southern Ethiopia: A Case Control Study
2019
[11] Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study
2019
[12] Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance
2019
[13] Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study
2019
[14] First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017
2019
[15] Clinical Risk Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) in Mali
2019
[16] Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014–2015
2018
[17] Kejadian Tuberkulosis Multi Drug Resistant di RSUP dr. Kariadi
2018
[18] ASSOCIATION OF MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS AND DIABETES MELLITUS
2018
[19] Antituberculosis-drug resistance in the border of Brazil with Paraguay and Bolivia/Resistencia as drogas antituberculose na fronteira do Brasil com Paraguai e Bolivia
Revista Panamericana de Salud Publica, 2017
[20] Structural analysis of the mycobacterium tuberculosis redox defence network reveals a unique bi-fan motif design associated with hydrogen peroxide reduction.
2017
[21] Resistência às drogas antituberculose na fronteira do Brasil com Paraguai e Bolívia
2017
[22] Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security
Emerging infectious diseases, 2017
[23] Assess drug resistance pattern and genetic profile of Mycobacterium tuberculosis clinical isolates by molecular typing methods using direct repeats and IS6110 in pulmonary tuberculosis cases
Lung India, 2017
[24] Antituberculosis-drug resistance in the border of Brazil with Paraguay and Bolivia
Resistência às drogas , 2017
[25] Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan.
2017
[26] Gambaran Karakteristik Pasien TB-MDR Dengan Diabetes Melitus di Rumah Sakit Umum Pusat Haji Adam Malik Medan Tahun 2016
2017
[27] TO EVALUATE PREVALENCE OF DIABETES AND HIV IN NEWLY-DIAGNOSED MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS ADMITTED FOR PRETREATMENT EVALUATION IN DOTS PLUS CENTRE, THANJAVUR
J. Evid. Based Med. Healthc., 2017
[28] Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan
2017
[29] Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia
2016
[30] Pattern of prevalence, risk factors and treatment outcomes among Egyptian patients with multidrug resistant tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis, 2016
[31] ارزیابی عوامل مرتبط بر منفی شدن اسمیر خلط بیماران سل ریوی در پایان ماه دوم درمان‎
2016
[32] Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan
PloS one, 2016
[33] Evaluating related factors with sputum smear negation at the end of the second month of tuberculosis treatment
2016
[34] Prevalence and Genetic Variation among Drug Resistance Genes of Mycobacterium tuberculosis
2015
[35] RISK FACTORS FOR MULTI DRUG-RESISTANT TUBERCULOSIS AMONG TUBERCULOSIS PATIENTS OF NEKEMTE REFERRAL HOSPITAL, OROMIA …
[36] TO EVALUATE PREVALENCE OF DIABETES AND HIV IN NEWLY-DIAGNOSED MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS ADMITTED FOR …